Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May 27:5:249.
doi: 10.3389/fmicb.2014.00249. eCollection 2014.

Malaria drives T cells to exhaustion

Affiliations
Review

Malaria drives T cells to exhaustion

Michelle N Wykes et al. Front Microbiol. .

Abstract

Malaria is a significant global burden but after >30 years of effort there is no vaccine on the market. While the complex life cycle of the parasite presents several challenges, many years of research have also identified several mechanisms of immune evasion by Plasmodium spp. Recent research on malaria, has investigated the programmed cell death-1 (PD-1) pathway which mediates exhaustion of T cells, characterized by poor effector functions and recall responses and in some cases loss of the cells by apoptosis. Such studies have shown exhaustion of CD4(+) T cells and an unappreciated role for CD8(+) T cells in promoting sterile immunity against blood stage malaria. This is because PD-1 mediates up to a 95% reduction in numbers and functional capacity of parasite-specific CD8(+) T cells, thus masking their role in protection. The role of T cell exhaustion during malaria provides an explanation for the absence of sterile immunity following the clearance of acute disease which will be relevant to future malaria-vaccine design and suggests the need for novel therapeutic solutions. This review will thus examine the role of PD-1-mediated T cell exhaustion in preventing lasting immunity against malaria.

Keywords: B cells; CD4+ T cells; CD8+ T cell; PD-1; PD-L1; chronic disease; exhaustion; malaria.

PubMed Disclaimer

References

    1. Agata Y., Kawasaki A., Nishimura H., Ishida Y., Tsubata T., Yagita H., et al. (1996). Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8 765–772 10.1093/intimm/8.5.765 - DOI - PubMed
    1. Alonso P. L., Sacarlal J., Aponte J. J., Leach A., Macete E., Aide P., et al. (2005). Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 366 2012–2018 10.1016/S0140-6736(05)67669-6 - DOI - PubMed
    1. Beattie L., Engwerda C. R., Wykes M., Good M. F. (2006). CD8+ T lymphocyte-mediated loss of marginal metallophilic macrophages following infection with Plasmodium chabaudi chabaudi AS. J. Immunol. 177 2518–2526 10.4049/jimmunol.177.4.2518 - DOI - PubMed
    1. Bhadra R., Gigley J. P., Weiss L. M., Khan I. A. (2011). Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc. Natl. Acad. Sci. U. S. A. 108 9196–9201 10.1073/pnas.1015298108 - DOI - PMC - PubMed
    1. Butler N. S., Moebius J., Pewe L. L., Traore B., Doumbo O. K., Tygrett L. T., et al. (2012). Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat. Immunol. 13 188–195 10.1038/ni.2180 - DOI - PMC - PubMed